有恶臭 发表于 2025-3-23 11:43:29
Antibody Engineering in Translational Medicineases. Antibody engineering technologies aim at the development of new generations of antibody-based drugs with more favorable properties, including higher potency or improved safety profiles. This chapter provides an overview over current strategies to tailor Abs for medical applications. While someARC 发表于 2025-3-23 14:53:17
http://reply.papertrans.cn/32/3111/311029/311029_12.png提名的名单 发表于 2025-3-23 20:26:41
http://reply.papertrans.cn/32/3111/311029/311029_13.pngexceed 发表于 2025-3-23 23:24:21
Engineering Multivalent and Multispecific Protein TherapeuticsTheir mechanisms of action have served as inspiration for the development of next-generation protein therapeutics with improved efficacy and safety profiles. Protein therapeutics leverage the inherent affinity and specificity of protein–protein interactions, offering an effective approach for targetIDEAS 发表于 2025-3-24 02:46:40
http://reply.papertrans.cn/32/3111/311029/311029_15.png外面 发表于 2025-3-24 07:23:59
http://reply.papertrans.cn/32/3111/311029/311029_16.pngIndent 发表于 2025-3-24 11:26:08
Engineering DNA Vaccines for Cancer Therapyand/or cellular immunity against tumor cells expressing the encoded antigen. Dozens of DNA vaccines have entered clinical trials for a variety of malignancies, where they have demonstrated efficacy in eliciting immune responses and potential clinical responses. This is further demonstrated by the ap助记 发表于 2025-3-24 17:10:33
https://doi.org/10.1007/978-1-4471-4372-7Engineering of Clinical Imaging Systems; Nanoengineering; Protein Engineering; Stem Cell Engineering; TiALB 发表于 2025-3-24 19:34:22
http://reply.papertrans.cn/32/3111/311029/311029_19.png新娘 发表于 2025-3-25 00:22:49
http://reply.papertrans.cn/32/3111/311029/311029_20.png